OraSure Technologies reported $100K in Loan Capital for its fiscal quarter ending in December of 2025.





Loan Capital Change Date
Agilent USD 3.64B 594M Jun/2026
AngioDynamics USD 5.6M 100K Sep/2025
Becton, Dickinson and Co. USD 13.42B 89M Sep/2026
Bio Techne USD 200M 0 Jun/2026
Bio-Rad Laboratories USD 803.1M 100K Sep/2026
Bruker USD 1.7B 111.7M Sep/2026
Cerus USD 64.86M 22K Dec/2024
Charles River Laboratories USD 2.44B 176.52M Sep/2026
Danaher USD 24.39B 759M Sep/2026
Dentsply International USD 1.98B 11M Sep/2026
Dexcom USD 1.3B 200K Jun/2026
Illumina USD 1.79B 298M Sep/2026
Integra LifeSciences USD 1.83B 2.12M Sep/2026
Intuitive Surgical USD 0 0 Mar/2025
IQVIA Holdings USD 14.82B 1.12B Sep/2026
Mesa Laboratories USD 104.2M 104.3M Sep/2024
Mettler Toledo International USD 1.96B 81.23M Sep/2026
Myriad Genetics USD 120.7M 400K Jun/2026
OraSure Technologies USD 100K 17K Dec/2025
Quidel USD 2.51B 22.5M Sep/2026
Repligen USD 555.6M 4.55M Sep/2026
Revvity USD 2.63B 968K Sep/2026
STAAR Surgical USD 42K 42K Dec/2023
Thermo Fisher Scientific USD 39.11B 73M Sep/2026
Trinity Biotech USD 26.69M 10.36M Mar/2026
Waters USD 5.09B 129M Jun/2026